STOCKIQ
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Insmed Inc (INSM)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· US· insmed.com
Trade INSM on Webull
3/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)43%

Our last 30 days of resolved calls came true 29% of the time.See the track record →

Price
$122.58
1 day
+2.22%
1 week
-6.89%
1 month
-1.56%
1 year
-16.22%
Market cap
$26.8B
Company fundamentals
EPS (TTM)
$-4.10
Debt / Equity
0.96
Current ratio
3.72
Operating margin
-73.9%
Net margin
-76.9%
Gross margin
83.5%
Return on equity
-111.3%
Revenue growth (YoY)
185.8%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$120.74$125.03
Stop-loss (exit)
$110.32 −10%
Target (exit)
$147.10 +20%

A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 Dominant catalyst: macro, as the move aligns with broad market and sector-wide trading patterns rather than company-specific news. Continuation likelihood: moderate-to-low, given the lack of a fundamental driver and reliance on market sentiment. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.